To compare health-related quality of life (HRQoL) between patients receiving care in Veterans Administration (VA) settings (veterans) and non-VA settings (nonveterans), and to explore determinants of HRQoL and change in HRQoL over time in subjects living with HIV/AIDS. however, in multivariable models, veteran status was only a significant determinant of SG and Tro values at baseline. Among other determinants that were associated with multiple HRQoL outcomes in baseline and follow-up multivariable analyses were: symptom bother, overall function, religiosity/spirituality, depressive symptoms, and financial worries.
H
ighly active antiretroviral therapy (HAART) has transformed HW/AIDS from a progressive, fatal illness to a treatable chronic disease. However, improved HIV control with antiretroviral therapy may come at the expense of substantial adverse drug effects. 1-4 Even with improved treatment and survival, H1V/AIDS can still compromise health-related quality of life (HRQoL), especially for those with side-effects from treatment and/or with more advanced disease. [5] [6] [7] [8] [9] There are 2 standard approaches to assessing HRQoL: the health status approach, which describes functioning and the impact of illness on 1 or more domains of health, and the health value/utility/preference approach, which assesses the desirability of states of health against an external metric. The literature contains many published studies addressing health status in HIV/AIDS 6-12 but only a few addressing symptoms 1a-I~ and health values s'16-1s in HIV/ AIDS.
The Veterans Health Administration (VHA) is the largest single provider of HIV care in the United States. 19 .20 Several studies have evaluated HRQoL in veterans, 21-24 and although one might expect HRQoL to differ in veterans compared with nonveterans with HW because of differences in socioeconomic status, life experiences, and comorbidities, only I study published to date has directly compared HRQoL between veterans and nonveterans with HIV. 21 That study found a difference in HRQoL between patients cared for at a Veterans Affairs (VA) and a university-based clinic; therefore, it is difficult to know how generalizable studies performed exclusively in veterans or in nonveterans with HW/AIDS may be.
Although various associations between HRQoL and other factors have been reported in a number of studies of patients with HW/AIDS, those factors have mostly been limited to demographic and clinical parameters, s-11'16-1s Furthermore, few studies have assessed determinants of change in HRQoL for patients with HW/AIDS. 17, 22, 26 Using a conceptual framework based on the work of Wilson and Cleary 27 and Tsevat, 28 as well as our prior experience studying HRQoL in subjects with HIV 5'16 (see manuscript by Szaflarski et al. in this supplement for a complete description of our conceptual model), we hypothesized that additional variance in HRQoL might be explained via certain clinical factors (such as depression, injection drug use, and alcohol use), demographic/life experi-$39 IGIM ence factors (such as being a veteran or parent), and nonhealth-related factors such as spirituality and religion, social support, and personality traits such as risk attitude and self-esteem. Thus, we designed a study with 3 objectives:
1. For patients with HIV/AIDS, to compare HRQoL in those cared for in VA settings (veterans) with those cared for in non-VA settings (nonveterans), 2. To explore determinants of HRQoL in subjects living with HW/AIDS. and 3 . To explore determinants of change in HRQoL over time.
METHODS

Study Design
We developed a structured questionnaire that we administered to a convenience sample of H1V-infected patients. This analysis includes complete data from the baseline interviews that took place during 2002 and 2003, as well as follow-up interviews that occurred 12 to 18 months later.
Subjects
We recruited outpatients with HW/AIDS from 4 sites in 3 cities: the University of Cincinnati Medical Center, the Cincinnati VA Medical Center, the VA Pittsburgh Healthcare System, and George Washington University Medical Center. The institutional review boards of the participating institutions approved the study. Subjects gave written informed consent and were compensated $30 for their time and travel expenses for each interview.
Interviews
Data were obtained primarily by patient questionnaires and supplemented by chart review for treatment and clinical information. Health ratings and health values were assessed by a trained interviewer using a laptop computer running U-Maker utility assessment software (Frank Sonnenberg, New Brunswick, NJ).
Outcomes
Our HRQoL outcomes included health status (specifically functional status and symptom bother), health ratings, and health values (specifically standard gamble [SG] and time tradeoff [TYO] utilities). Functional status, symptom bother, and health ratings were also regarded as potential determinants of the other HRQoL outcomes.
Health Status. Functional status was measured using the Overall Function scale of the HIV/AIDS-Targeted Quality of Life (HAT-QoL) instrument. 29'3~ The HAT-QoL consists of 34 questions that assess 9 dimensions: sexual functioning; disc10sure worries; medication worries; health worries; financial worries; HIV mastery; life satisfaction; and provider trust, in addition to overall functioning. Each subscale is scored from 0 (worst) to 100 (best). The measure has been found to be reliable and valid, with the overall function domain having a Cronbach's a of 0.89. 29 Symptom Distress. We used the 20-question HIV Symptom Index (HSI; also known as the Symptoms Distress Module) to assess symptom distress. 23.31.32 Each of the 20 symptoms was endorsed on a 5-point Likert scale ranging from 0 to 4, with 0 representing the absence of that symptom and 4 indicating that the patient has the symptom and it bothers them "a lot." The HSI is strongly associated with the physical and mental health summary scales of the MOS-H1V measure and with disease severity, independent of CD4 cell count and viral load. 32
Health Ratings. We administered a health rating scale (RS) question in the form of a "feeling thermometer," in which subjects were asked to rate their current health state along a scale ranging from 0 (dead) to 100 (perfect health). The RS has been shown to have a same-day test-retest reliability of 0.86 to 0.94 and a 1-week test-retest reliability of 0.77. 33 Time Tradeoff. The TTO assesses one's willingness to live a shorter-but-healthier life. 33 The TTO was posed as a choice between living x years in one's present state of health versus (x-t) years in perfect health. We chose x to approximate the mean life expectancy among all subjects: 15 years. Time t was varied systematically in a ping-pong fashion 34 until an indifference point was found between living 15 years in one's current state of health and (I 5~) years in perfect health. The output of the TTO is a utility equal to (15-t)/15 such that scores range from 0 (dead) to 1 (perfect health); for ease of comparison with other HRQoL scales, we linearly transformed TI'O results to range from 0 to 100. The TTO has been found to have a test-retest reliability of 0.77 to 0.88. 33
SG.
The SG assesses one's willingness to risk immediate death in exchange for a chance of having perfect health. 33 The SG was posed as a choice between: (I) the certainty of living the rest of one's life in one's current state of health, or (2) a gamble between perfect health for the remainder of life with P versus immediate death with probability (l-P). The P was varied systematically in a ping-pong fashion until the subject was indifferent between preferring the certainty of living the rest of his/ her life in their current state of health and preferring the gamble. The indifference Pt equals the utility for the patient's current state of health. Here, too, we linearly transformed the results to range from 0 to 100. The SG hasbeen shown to have a test-retest reliability of 0.77 to 0.92. 33
Independent Variables
Demographics~Life Experience. Demographic data were selfreported by subjects. Data collected included date of birth, sex, race, sexual orientation, marital status, housing status (with housing situation considered to be unstable if subjects endorsed "transient/live in shelter" or "homeless"), education level, employment status, insurance status, number of children, number of other dependents, alcohol use, and injection drug use. If subjects received care at a VA Medical Center, then they were defined as veterans for our analyses; otherwise, they were considered nonveterans. We assessed religious affiliation by using a single item asking, "What is your religious preference?" Participants were given one of 20 specific religions and denominations from which to choose, or could choose "none," "other specific," or "undesignated." For analytical purposes, the variable was dichotomized as having a religion (the subject endorsed any of the 20 specific religions or endorsed "other specific") versus not having a religion (endorsed "none" or "'undesignated").
Disease Measures. Clinical data, collected from the medical record, included year diagnosed with HIV; history of opportunistic infections; lowest and current CD4 count; highest and current viral load; and current antiretroviral treatment.
Depressive Symptoms. We administered the 10-item Center for Epidemiological Studies-Depression Scale (CESD-10). 35 Each of the 10 questions captures the frequency of a particular mood or symptom in the prior week using a 4-point scale ranging from 0 (none of the time} to 3 {most of the time}. After reversing the positive mood items, scores on the items are summed such that they range from 0 {best} to 30 {worst}. 23 Religiosity. To address religiosity, we administered the Duke Religion Index, a 5-item measure assessing 3 aspects of religiousness: organized religious activity (attendance at religious services; scored from 1 [never] to 6 [more than once a week]), nonorganized religious activity (prayer, meditation, or text study; scored from 1 [never] to 6 [more than once a week]), and intrinsic religiosity (subjective views on religion and religious experience; scored from 3 to 15, with higher scores indicating greater intrinsic religiosity). 42 Because published psychometric properties are not available, we calculated the Cronbach's ct for the intrinsic religiosity subscale, which was 0.88.
Religious
Coping. We administered the Brief RCOPE, which was designed to offer an efficient, theoretically meaningful way to assess the roles of religion in coping. 43 The scale consists of 7 positive and 7 negative religious coping items derived from the full RCOPE through factor analysis. 44 The positive items assess the following types of positive religious coping: spiritual connection, seeking spiritual support, religious forgiveness, collaborative religious coping, benevolent religious reappraisals, religious purification, and religious focus. The negative items tap 5 types of negative religious coping: spiritual discontent, punishing God reappraisals, interpersonal religious discontent, demonic reappraisals, and reappraisals of God's powers. Participants responded to each item on a 4-point Likert-type scale to indicate how much or how frequently they used the particular way of coping ("not at all," "somewhat," "quite a bit," or "a great deal"). This brief scale has high internal consistency (ct=0.81 to 0.90) and good discriminant validity. 43
Health Concerns. Health concerns were measured by using 5 of 9 dimensions of the HAT-QoL: disclosure worries; health worries; financial worries; H1V mastery (comfort with how the patient acquired HIV); and provider trust. 29'3~ The instrument has been shown to exhibit good psychometric properties, including low ceiling/floor effects, good internal consistency, and construct validity. 29'3~ Self-Esteem. We used Rosenberg's 6-item global self-esteem measure, which consists of 3 positively framed items and 3 negatively framed items, each scored from 1 to 4. 45-47 A total score for the 6 items was calculated by summing the responses after reversing the negative ones. The Rosenberg measure has been found to have a Cronbach's ~ of 0.88. 48 Risk Attitude. To assess attitudes about taking risks, we administered the 6-item risk-taking scale from the Jackson Personality Index. 49 Response categories range from 1 (strongly agree) to 6 (strongly disagree). After reversing 3 items, resuits were summed to yield a score between 6 and 36, with higher scores indicating greater risk-seeking attitudes. The Cronbach's ~ for this version of the scale is 0.71. 49
Analyses
Descriptive statistics included means and SDs for continuous variables and percents for categorical variables. Missing data for the outcome measures were not imputed except that missing items on the HSI were considered to be 0 (i.e., that symptom was not present). As previously described by Kilbourne et a1.,23 because 5 items of the HSI (fatigue, memory, sadness, anxiety, and insomnia) relate closely to analogous elements of the CESD-10, we did not analyze those 5 HSI items. Of the remaining 15 items, we counted the number of symptoms considered to be bothersome ("it bothers me" or "it bothers me a lot"}, yielding a possible score between 0 and 15. 23 We developed multivariable linear regression models to assess correlates of HRQoL at baseline and follow-up. The follow-up models included the baseline variable value as a predictor and also baseline and change values for the potential predictor variables. In both the baseline and follow-up models, predictor variables significantly associated with the outcome variables in bivariate analyses at a P<. 10 level were entered as candidate variables into the models, as were additional variables found to be significant in previous research {e.g., age and race with functional status}. Final models were determined by using backwards elimination, retaining only significant factors (P<.05); however, to assess potential multicollinearity, elimination was not automated but was performed by hand, and robustness of the final models was assessed by substituting and adding variables felt possibly to be collinear. The final models were found to be robust to those evaluations. No corrections were made for multiple statistical analyses; however, P-values are presented. Analyses were conducted by using SAS, version 8.0 {SAS Institute, Cary, NC).
RESULTS
Participant Characteristics
Of the 450 subjects interviewed at baseline, 100 (22%} were veterans and 350 {78%) were nonveterans. The mean {SD) age Table 3 ). In multivariable analyses that included Depressive symptoms (0 to 30, higher score =more depressive symptoms) Health worries (0 to 100, higher score =fewer worries) Financial worries (0 to 100, higher score =fewer worries) H1V mastery (0 to 100, higher score =greater comfort) Disclosure worries (0 to 100, higher score =fewer worries) Provider trust (0 to 100, higher score =more trust) Perceived social support (12 to 48, higher score =more perceived support) Self-esteem (6 to 24, higher score =more self-esteem) Risk attitude (6 to 36, higher score =more risk-seeking) Spirituality (0 to 92, higher score =more spiritual) Organized religious activity (1 to 6, higher score =more religiously active) Nonorganized religious activity (1 to 6, higher score=more religiously active} Intrinsic religiosity (3 to 15, higher score=more religious) Positive religious coping (7 to 28, higher score =greater positive religious coping) Negative religious coping (7 to 28, higher score =greater negative religious coping) 
JGIM
Change in HRQoL Over Time. None of the mean HRQoL values
changed significantly over time (Table 3) . However, as noted by the SDs, there was substantial individual variability in HRQoL outcomes over time.
Determinants of HRQoL at Baseline
In bivariate assessments, a number of factors were significantly correlated with all HRQoL outcomes. Specifically, employment, significant depressive symptoms, health worries, financial worries, H1V mastery, provider trust, perceived social support, self-esteem, spirituality, symptom bother, and overall functioning were associated with HRQoL. Several other factors were significantly correlated with all but one of the HRQoL outcomes, and they included education, veteran status, duration of disease, history of AIDS-deFming conditions, disclosure worries, organized religious activity, and negative religious coping. In bivariate analyses, CD4 cell count and viral load were not significantly associated with health values but they were associated with other HRQoL outcomes (CD4 cell count with health ratings and both with health status). In multivariable analyses, HRQoL measures were significantly associated at baseline with a number of factors (Table 4) . In multiple multivariable models, less symptom bother; better overall function; fewer depressive symptoms; greater levels of spirituality; greater self-esteem; being employed; being a nonveteran; and having less severe disease were all associated with better HRQoL.
Correlates of HRQoL at Follow-up
Overall Function. In addition to higher baseline overall function score, improvement in the health worries score, higher baseline and improvement in the fnancial worries scores, employment, improvement in self-esteem, increase in level of organized religious activity, and positive change in positive religious coping score were all associated with improvements in overall function at follow-up, whereas veteran status was not (Table 5) . Greater baseline depressive symptomatology, increase in depressive symptoms, and positive change in intrinsic religiosity score were all associated with decreases in overall function at follow-up.
Number of Bothersome Symptoms. In addition to having more bothersome symptoms at baseline, female sex, increase in alcohol use, greater baseline depressive symptomatology, and increase in depressive symptoms over time--but not veteran status--were all associated with increased number of bothersome symptoms at follow-up. Improvement in the health worries score; higher baseline financial worries score and improvement in the financial worries score; and positive change in nonorganized religious activity score were all associated with fewer bothersome symptoms at follow-up.
Health Ratings. In addition to higher baseline health ratings, higher baseline and improved overall function, improved financial worries score, a past history of AIDS-defining conditions, and increased in organized religious activity score were all associated with improvements in health ratings at followup. Increase in the number of bothersome symptoms was associated with lower health ratings at follow-up. Veteran status had no effect on change in health ratings.
SG.
Although veteran status was not associated with change in SG values, higher baseline SG values, a past history of injection drug use, providing financial support for a child, improvement in provider trust score, a higher baseline and an improved self-esteem score, and an increase in nonorganized religious activity were all associated with increases in SG health values. More bothersome symptoms at baseline and an increase in the number of bothersome symptoms, as well as a higher baseline spirituality score, were all associated with decreases in SG values at follow-up.
Time Tradeoff. In addition to higher baseline Tro values, being heterosexual; having stable housing; having a religious affiliation; improved overall functioning at follow-up; being more risk-seeking; and having a higher level of spirituality at baseline were all associated with having higher Tro values at follow-up. More bothersome symptoms at baseline and an increase in number of bothersome symptoms were associated with lower Tro values at follow-up. Veteran status had no effect.
DISCUSSION
In this study, we assessed health status, health ratings, and health values in veterans and nonveterans with HIV infection twice over 12 to 18 months. We also assessed determinants of HRQoL and change in HRQoL over time.
We found that CD4 cell count and viral load were only associated with some of the HRQoL outcomes in bivariate analyses (with health status and health ratings but not with health values), and, in multivariable analyses, with none of the HRQoL outcomes at baseline or follow-up. Other clinical factors, such as symptoms (HIV-related or depressive), and other indicators of disease severity, such as duration of disease and history of an AIDS-defming condition, were more consistently associated with HRQoL and may be more pertinent clinical indicators of HRQoL in the HAART era. We found that HRQoL was stable, on average, over the 12 to 18 months of follow-up. Because at baseline the cohort had HIV for an average of more than 8 years, over 75% were being treated with HAART, and the mean CD4 cell count for the cohort was 420cells/gL, one might expect little change in HRQoL, on average, over the relatively brief time assessed. That said, there was substantial interindividual variation, with some subjects improving and others worsening. Our analyses add to the understanding of what contributes to that change.
Although several studies have assessed HRQoL outcomes in veterans with HIV, 13'14'24'50 our study directly compared HRQoL in veterans and nonveterans as only one other study 21 has done.
The authors of that study felt that the decrements in HRQoL for veterans could be related to differences in demographic and clinical factors such as age, employment, and CD4 cell counts, but they were unable to assess that hypothesis. Our study corroborates and expands upon that study, as we were able to account for differences in HRQoL via multivariable analyses: our finding that veterans reported significantly lower SG and TTO health values held true even after accounting for those and other differences in demographic and clinical characteristics. We speculate that those differences could be related to unmeasured differences in the cohorts, such as life experiences (i.e., military service) or literacy. Whatever the reason, the difference in health value results for vet-$45 We were able to identify several interesting associations with HRQoL or with changes in HRQoL that could potentially be targets for interventions to improve HRQoL. Levels of spirituality/ religiosity were associated with all baseline and follow-up HRQoL outcomes except for symptom bother at Time 1. Baseline level of spirituality was associated with TI'O values both at baseline and follow-up, possibly implying that people with higher levels of spirituality may be less willing to trade time. Interestingly, chmlge in positive religious coping and religious activity (organized and nonorganized) were consistently shown to relate to HRQoL outcomes (health status, health ratings, and health values) at followup. While we do not conclude that spirituality/religiosity affects HIV disease directly, its consistent association with HRQoL and change in HRQoL over time may represent a role of spirituality/ religiosity in adaptation to HIV disease. Additionally, although there have been several studies that have elucidated the impact of symptoms on health status in patients with chronic viral illnesses, 13-15"2a'a2 limited information exists on the impact of symptoms on health values, 51 and our study adds new insights on that relationship.
The statistical significance of symptom bother (and/or change in symptom bother) in the multivariable models emphasizes the importance of better understanding the impact of symptoms and of the need to explore the association of specific symptoms with HRQoL. If certain specific symptoms are strongly associated with HRQoL or with change in HRQoL, then perhaps those key symptoms could be targets of interventions. Also, we found that depressive symptoms and change in the depressive symptoms score are significantly correlated with change in health status (functional status and symptom bother) and health ratings. The importance of depressive symptoms vis-a-vis health status in patients with H1V has been noted previously, 1a'26 and our results support identifying and treating depression in patients with HIV to improve their HRQoL. Health worries and/or financial worries were associated with change in overall function, symptom bother, and health ratings. Patients' concems regarding their health and Finances have not typically been part of most generic or HIV-specific quality of life assessments; however, our findings would support their validity as well as the need to include them in future HRQoL studies in HIV/AIDS. This study had several strengths and limitations. Strengths included having 4 study sites, including both veterans and nonveterans, having a large sample (ours is the largest study of directly derived health values in subjects with H1V), and including a number of unique potential determinants of HRQoL. Limitations relate to the generalizabflity. The subjects in this study were recruited from tertiary care sites in 3 cities and Hispanics, women, and active drug users were under-represented; therefore, our results may not be generalizable to all patients receiving (or not receiving) care for HIV. Also, we were only able to report associations with HRQoL without knowing the direction of the association (i.e., whether the factor drove the HRQoL level or the HRQoL level drove the factor).
In conclusion, veterans with HIV have significantly poorer HRQoL than nonveterans, but when controlling for other factors, veteran status is only a significant determinant of health values. A number of correlates of HRQoL, such as symptom bother, spirituality/religiosity, depressive symptoms, health worries, and financial worries could be fruitful targets for interventions to improve HRQoL in patients with HlV/AiDS.
